Liang Zhong
Key Laboratory Of Laboratory Medical Diagnostics
Chongqing, 400016, China
Chongqing, 400016, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 80 publications
TRIM24 stabilizes the p110 CUX1 oncoprotein via USP10 to promote chemoresistance in acute myeloid leukemia.
Journal: Journal of translational medicine
Published: March 01, 2026
Pristimerin enhances erastin-induced ferroptosis in AML cells via the ATF3/SLC7A11 axis.
Journal: Naunyn-Schmiedeberg's archives of pharmacology
Published: January 21, 2026
MYLIP-dependent ubiquitination and degradation of LDLR in acute myeloid leukemia and MAPK signaling.
MYLIP-dependent ubiquitination and degradation of LDLR in acute myeloid leukemia and MAPK signaling.
Journal: Molecular and cellular probes
Published: December 31, 2025
IRF2-driven upregulation of OAS3 promotes AML cell proliferation by modulating the JAK-STAT signaling pathway.
Journal: Biochemical and biophysical research communications
Published: April 08, 2025
Unraveling the oncogenic and immunomodulatory roles of GINS1: a systematic pan-cancer study.
Journal: Cancer cell international
Published: March 30, 2025
A Dendrobium chrysotoxum extract erianin induce AML cells death by activating PPARɑ and downregulating PI3K/AKT signaling pathways.
Journal: Toxicon : official journal of the International Society on Toxinology
Published: March 17, 2025
Research on the evaluation of canal route schemes based on multiattribute decisionmaking methods.
Journal: Scientific reports
Published: February 28, 2025
OTUB1 promotes the progression of acute myeloid leukemia by regulating glycolysis via deubiquitinating c-Myc.
Journal: Cellular signalling
Published: November 19, 2024
NACC1 accelerates the progression of AML by regulating the ADAM9/PI3K/AKT axis.
Journal: International journal of medical sciences
Published: August 12, 2024
p110CUX1 promotes acute myeloid leukemia progression via regulating pyridoxal phosphatase expression and activating PI3K/AKT/mTOR signaling pathway.
Journal: Molecular carcinogenesis
Published: March 05, 2024
p200CUX1-regulated BMP8B inhibits the progression of acute myeloid leukemia via the MAPK signaling pathway.
Journal: Medical oncology (Northwood, London, England)
Published: February 24, 2024
Last Updated: 09/26/2026